Althea adds new aseptic fill/finish line amid cost concerns

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/RGtimeline)
(Image: iStock/RGtimeline)
Ajinomoto Althea, Inc. has added a new aseptic fill/finish line in response to client's concerns regarding active pharmaceutical ingredient (API) manufacturing costs.

The San Diego, CA-based contract development and manufacturing organization (CDMO) installed the Optima VFVM 7000 aseptic fill/finish line.

"All of our clients are concerned with the cost of manufacturing API. The ability to maximize yield from the filling line was a key driver for this project​," Stacy Sutton, head of engineering at Althea told

"This line has the capability to use two different pumping systems, rotary piston and peristaltic. The ability to use single use disposable filling assemblies in conjunction with peristaltic pumps is a key feature​," she added.

The line also has features to minimize drug product loss, including start and end of production modes, Sutton explained.

Additionally, the new line enables larger batch sizes and a wider filling volume range (0.2 mL up to 100 mL). The equipment also provides 100% in-process-control and nitrogen purging.

Related news

Related products

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...


Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Related suppliers